Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AFTER-VT: Antiarrhythmics After VT Ablation
NCT04208997Phase 3Terminated
- Sponsor
- Vanderbilt University Medical Center
- Start
- Dec 2019
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of amiodarone and sotalol in ventricular tachycardia (VT) (2 arms), sponsored by Vanderbilt University Medical Center. Primary endpoint: Number of Participants Dead or With VT Recurrence at One Year at 1 year. Started Dec 2019; status: terminated.
02
Drugs
amiodaronesotalol
03
Conditions
ventricular tachycardia (VT)
Beyond the preview
Go deeper on NCT04208997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04208997.